Paper41345602
Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States.
Shin T and 7 others. BMC Public Health, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States. Papers, record 41345602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41345602
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Meningococcal Vaccines | Major topic |
| Immunization Schedule | Major topic |
| Meningococcal Infections | Major topic |
| Humans | |
| Cost-Benefit Analysis | |
| United States | |
| Adolescent | |
| Cost-Effectiveness Analysis | |
| Young Adult | |
| Quality-Adjusted Life Years | |
| Child | |
| Adult | |
| Male | |
| Incidence | |
| Female |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35840033 | Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme. | Clin Microbiol Infect | 2022 | https://conductscience.org/library/papers/35840033 | PubMed |
| 2 | 32228726 | Meningococcal carriage in Norwegian teenagers: strain characterisation and assessment of risk factors. | Epidemiol Infect | 2020 | https://conductscience.org/library/papers/32228726 | PubMed |
| 3 | 39173168 | National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023. | MMWR Morb Mortal Wkly Rep | 2024 | https://conductscience.org/library/papers/39173168 | PubMed |
| 4 | 28472165 | Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada. | PLoS One | 2017 | https://conductscience.org/library/papers/28472165 | PubMed |
| 5 | 25505298 | Meningococcal carriage among Georgia and Maryland high school students. | J Infect Dis | 2015 | https://conductscience.org/library/papers/25505298 | PubMed |
| 6 | 27623463 | Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. | JAMA | 2016 | https://conductscience.org/library/papers/27623463 | PubMed |
| 7 | 33631080 | Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine. | Hum Vaccin Immunother | 2021 | https://conductscience.org/library/papers/33631080 | PubMed |
| 8 | 40394570 | Understanding the value of meningococcal vaccination for adolescents and young adults in the United States: insights from a steady-state modelling approach. | BMC Public Health | 2025 | https://conductscience.org/library/papers/40394570 | PubMed |
| 9 | 38048433 | United States Life Tables, 2021. | Natl Vital Stat Rep | 2023 | https://conductscience.org/library/papers/38048433 | PubMed |
| 10 | 28027288 | Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada. | Pediatr Infect Dis J | 2017 | https://conductscience.org/library/papers/28027288 | PubMed |
| 11 | 12586669 | Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. | BMJ | 2003 | https://conductscience.org/library/papers/12586669 | PubMed |
| 12 | 23741448 | Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands. | PLoS One | 2013 | https://conductscience.org/library/papers/23741448 | PubMed |
| 13 | 35641955 | Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review. | BMC Public Health | 2022 | https://conductscience.org/library/papers/35641955 | PubMed |
| 14 | 34791633 | Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM). | Infect Dis Ther | 2022 | https://conductscience.org/library/papers/34791633 | PubMed |
| 15 | 17560695 | Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis. | Vaccine | 2007 | https://conductscience.org/library/papers/17560695 | PubMed |
| 16 | 16110936 | Academic and behavioral limitations and health-related quality of life in school-age survivors of bacterial meningitis. | Qual Life Res | 2005 | https://conductscience.org/library/papers/16110936 | PubMed |
| 17 | 31301916 | Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents. | Vaccine | 2019 | https://conductscience.org/library/papers/31301916 | PubMed |
| 18 | 27002504 | Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France. | Vaccine | 2016 | https://conductscience.org/library/papers/27002504 | PubMed |
| 19 | 38242365 | Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia 2017-2020. | J Infect | 2024 | https://conductscience.org/library/papers/38242365 | PubMed |
| 20 | 33431159 | Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease. | Value Health | 2021 | https://conductscience.org/library/papers/33431159 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42702664 | Burden of Invasive Meningococcal Disease: Evolving Epidemiology and Implications for Prevention Policy. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/42702664 | PubMed |
| 41790381 | Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States. | Pharmacoeconomics | 2026 | https://conductscience.org/library/papers/41790381 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41345602
GET https://conductscience.org/api/papers/v1/41345602/references?page=2